JNJ-75276617
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JNJ-75276617, covering 2025-06-22 to 2025-06-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias [Phase 1]